semaglutide and breast cancer decelerates the growth progression of by enhancing the acquired antitumor immunity Frontiers | GLP-1 receptor agonist
Description
If you are losing patience with the gradual approach and find yourself skipping doses or losing motivation, the psychological cost of microdosing may outweigh the physiological benefit
GLP-1 weight loss is gradual, and AHI improvement follows weight loss with a lag
Endocrinology 1999;140:535663
Weeks 5-8: The Challenge Phase (4mg Dose) Starting Weight Week 5: ~216 pounds | Expected Weight Week 8: 209-212 pounds | Net Loss This Period: 4-7 pounds | Total Loss: 8-11 pounds Whats Happening Physiologically Dose doubles from 2mg to 4mg
